Delving into the Latest Updates on Suntory Pharmaceutical Research Laboratories LLC with Synapse

A Phase 3 Study to Demonstrate the Safety and Efficacy of Recombinant Platelet-Activating Factor Acetylhydrolase (rPAF-AH, Pafase®) for Reducing 28 Day All Cause Mortality in Patients With Severe Sepsis

The objective of this study is to demonstrate that rPAF-AH is safe and reduces 28 day all cause mortality in patients with severe sepsis.

开始日期2001-04-01

申办/合作机构

ICOS Corp.

[+1]

NCT00030121 / Completed临床2期

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Evaluation of the Safety and Efficacy of Carperitide Infusion in Patients With ARDS

The purpose of this study is to determine whether Carperitide is safe and effective in the management of Acute Respiratory Distress Syndrome (ARDS).

开始日期1999-12-01

申办/合作机构

Suntory Pharmaceutical Research Laboratories LLC

100 项与 Suntory Pharmaceutical Research Laboratories LLC 相关的临床结果

登录后查看更多信息

0 项与 Suntory Pharmaceutical Research Laboratories LLC 相关的专利（医药）

登录后查看更多信息

1

项与 Suntory Pharmaceutical Research Laboratories LLC 相关的文献（医药）

Toward an understanding of human parathyroid hormone structure and function

作者: Jin, Lei ; Zhang, Faming ; Tashjian, Armen H. Jr.

A review.Parathyroid hormone (PTH) is synthesized as a 115 amino acid precursor and secreted as an 84 amino acid polypeptide that regulates extracellular calcium homeostasis via actions directly on kidney and bone and indirectly on the intestine by facilitating absorption.The structural determination and structural based design of PTH are discussed.

100 项与 Suntory Pharmaceutical Research Laboratories LLC 相关的药物交易

登录后查看更多信息

100 项与 Suntory Pharmaceutical Research Laboratories LLC 相关的转化医学

登录后查看更多信息